CeCe Moore at Your Genetic Genealogist takes a close look at commercially available genetic ancestry tests from Family Tree DNA, Ancestry DNA, 23andMe, and National Geographic's Geno 2.0.

Moore finds that 23andMe matches her known ancestry the most closely and is the "most informative and flexible" but not without a few caveats. For example, it assigned some Finnish ancestry to her paternal side when it should all have come from her maternal side.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.